Holger Wenschuh, PhD
(Managing Director)
Dr. Holger Wenschuh is Managing Director at JPT Peptide Technologies since 2004. Before he served as Business Unit Manager at Jerini AG and Managing Director at Chemotopix GmbH. Dr. Wenschuh studied Chemistry at the Friedrich-Schiller-University in Jena, Germany, and obtained his PhD in Organic Chemistry at the Institute of Molecular Pharmacology in Berlin, Germany. He worked at the University of Massachusetts and Perseptive Biosystems, USA and from 1995 to 1997, he headed the Peptide Unit at the Max-Planck-Institute of Infection Biology in Berlin.
Dr. Wenschuh is author and co-author of numerous publications, co-inventor on several patents and editorial board member of the International Journal of Peptide Research and Therapeutics.

Ulf Reimer, PhD
(Head of Research & Development)
Dr. Ulf Reimer is Head of Research and Development at JPT since 2009. He studied Biochemistry at Martin-Luther University Halle/Wittenberg. He worked for his PhD Thesis at the research group of the Max-Planck-Society “Enzymology of Protein Folding” at Halle/Saale. From 1998 to 2000 he was a postdoctoral researcher at this research group and at the group of Prof. Griesinger at the University of Frankfurt/Main. Later he joined Jerini AG in Berlin, where he started as a scientist and was later jointly responsible for drug discovery and development projects as Director Computational Chemistry in the middle management of Jerini AG.
Dr. Reimer is author and co-author of a considerable number of publications, and co-inventor on many patents.